Promising genes and variants to reduce chemotherapy adverse effects in acute lymphoblastic leukemia

Promising genes and variants to reduce chemotherapy adverse effects in acute lymphoblastic leukemia

Almost two decades ago, the sequencing of the human genome and high throughput technologies came to revolutionize the clinical and therapeutic approaches of patients with complex human diseases. In acute lymphoblastic leukemia (ALL), the most frequent childhood malignancy, these technologies have en...

Full description

Bibliographic Details
Main Authors: Diego Alberto Bárcenas-López, Diana Karen Mendiola-Soto, Juan Carlos Núñez-Enríquez, Juan Manuel Mejía-Aranguré, Alfredo Hidalgo-Miranda, Silvia Jiménez-Morales
Format: Article
Language:English
Published: Elsevier 2021-01-01
Series:Translational Oncology
Subjects:
Acute lymphoblastic leukemia
Pharmacogenes
Polymorphisms
Treatment response
Personalized medicine
Online Access:http://www.sciencedirect.com/science/article/pii/S1936523320304708

Internet

http://www.sciencedirect.com/science/article/pii/S1936523320304708

Similar Items